Arteris/$AIP
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Arteris
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum its revenue from Asia Pacific.
- Ticker
- $AIP
- Sector
- Software & Cloud Services
- Primary listing
- NASDAQ
- Employees
- 364
- Headquarters
- Campbell, United States
- Website
- www.arteris.com
Arteris Metrics
BasicAdvanced
$924M
-
-$0.88
1.91
-
Price and volume
Market cap
$924M
Beta
1.91
52-week high
$50.26
52-week low
$12.06
Average daily volume
611K
Financial strength
Current ratio
1.568
Quick ratio
1.471
Long term debt to equity
0.087
Total debt to equity
0.128
Interest coverage (TTM)
-219.82%
Profitability
EBITDA (TTM)
-33.042
Gross margin (TTM)
87.61%
Net profit margin (TTM)
-46.70%
Operating margin (TTM)
-44.42%
Effective tax rate (TTM)
6.26%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
-14.17%
Return on equity (TTM)
-131.41%
Valuation
Price to revenue (TTM)
9.96
Price to book
13.63
Price to tangible book (TTM)
67.77
Price to free cash flow (TTM)
124.562
Free cash flow yield (TTM)
0.80%
Free cash flow per share (TTM)
0.151
Growth
Revenue change (TTM)
33.81%
Earnings per share change (TTM)
7.83%
3-year revenue growth (CAGR)
17.86%
3-year earnings per share growth (CAGR)
-3.16%
What the Analysts think about Arteris
Analyst ratings (Buy, Hold, Sell) for Arteris stock.
Analyst projections of the future price of Arteris stock.
Bulls say / Bears say
Q2 revenue rose 46% to $24.1 million, while ACV plus royalties climbed 44% to $99.5 million and remaining performance obligations grew 36% to $135 million. Management raised its 2026 revenue outlook to $95–$98 million, giving the growth story stronger near-term visibility. (SEC)
Customer-confirmed design starts increased 21% year on year, and a major hyperscaler selected Arteris as its standard interconnect technology for future data-centre chips. No customer accounted for more than 10% of first-half revenue, which limits reliance on any one buyer. (The Motley Fool)
Arteris has expanded its chiplet offering with FlexGen Multi-Die for AI and high-performance computing designs. The company says the technology can reduce die-to-die PHY area, power and I/O needs by up to 50%; successful adoption could create another way to benefit from more complex chip designs. (Arteris)
Arteris raised $72.5 million through an at-the-market share sale in Q2. That strengthens its cash position, but issuing shares dilutes existing investors. (The Motley Fool)
Design wins can take years to generate royalties: Arteris says customers typically begin shipping products using its IP one to five years after completing a design. Delays, weaker demand or trade restrictions affecting customer markets could therefore postpone or reduce royalty income. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 30 Oct 2026.
Arteris Financial Performance
Revenues and expenses
Arteris Earnings Performance
Company profitability
Upcoming events
No upcoming events
Arteris News
AllArticlesVideos
Funds containing Arteris
Fund name | Fund size | $AIP weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.02% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.02% |
iShares MSCI World Small Cap£WLDS | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | $9B | 0.01% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.